Cargando…
Two Is Better Than One: Evidence for T-Cell Cross-Protection Between Dengue and Zika and Implications on Vaccine Design
Dengue virus (DENV, family Flaviviridae, genus Flavivirus) exists as four distinct serotypes. Generally, immunity after infection with one serotype is protective and lifelong, though exceptions have been described. However, secondary infection with a different serotype can result in more severe dise...
Autores principales: | Subramaniam, Krishanthi S., Lant, Suzannah, Goodwin, Lynsey, Grifoni, Alba, Weiskopf, Daniela, Turtle, Lance |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109261/ https://www.ncbi.nlm.nih.gov/pubmed/32269575 http://dx.doi.org/10.3389/fimmu.2020.00517 |
Ejemplares similares
-
Human T Cell Response to Dengue Virus Infection
por: Tian, Yuan, et al.
Publicado: (2019) -
Modified vaccinia Ankara–Bavarian Nordic vaccine against mpox in children
por: Turtle, Lance, et al.
Publicado: (2023) -
Global Assessment of Dengue Virus-Specific CD4(+) T Cell Responses in Dengue-Endemic Areas
por: Grifoni, Alba, et al.
Publicado: (2017) -
T-Cell Immunity to Infection with Dengue Virus in Humans
por: Weiskopf, Daniela, et al.
Publicado: (2014) -
The Challenges Imposed by Dengue, Zika, and Chikungunya to Brazil
por: Zanotto, Paolo Marinho de Andrade, et al.
Publicado: (2018)